The invention concerns the use of N-(2-[-(RS-2-hydroxy-3-(4-hydroxyphenoxy)propylamino)ethyl)-morpholinoform- amide or a salt thereof in the production of a medicament for the treatment of obesity and/or related conditions in warm-blooded animals including man.
本发明涉及 N-(2-[-(RS-2-羟基-3-(
4-羟基
苯氧基)丙基
氨基)乙基]-
吗啉酰胺或其盐在生产治疗包括人类在内的温血动物肥胖症和/或相关疾病的药物中的用途。